Photo by mohamed hassan form PxHere
A world-first trial has shown that nose drops of modified ‘friendly’ bacteria protect against meningitis.
Led by Professor Robert Read and Dr Jay Laver from the NIHR Southampton Biomedical Research Centre and the University of Southampton, the work is the first of its kind.
Together they inserted a gene into a harmless type of a bacteria, that allows it to remain in the nose and trigger an immune response. They then introduced these bacteria into the noses of healthy volunteers via nose drops.
The results, published in the journal Science Translational Medicine, showed a strong immune response against bacteria that cause meningitis and long-lasting protection.
Protecting against meningitis
Meningitis occurs in people of all age groups but affects mainly infants, young children and the elderly. Meningococcal meningitis, is a bacterial form of the disease, causing 1,500 cases a year in the UK. It can lead to death in as little as four hours after symptoms start.
Around 10% of adults carry N. meningitidis in the back of their nose and throat with no signs or symptoms. However, in some people it can invade the bloodstream. That can lead to life-threatening conditions including meningitis and blood poisoning (‘septicaemia).
The ‘friendly’ bacteria Neisseria lactamica (N. lactamica) also lives in some people’s noses naturally. By occupying the nose, it protects from a severe type of meningitis. It does so by denying a foothold to its close cousin Neisseria meningitidis (N. meningitidis).
Enhanced immune response
The new data build on the team’s previous work aiming to exploit this natural phenomenon. That study showed nose drops of N. lactamica prevented N. meningitidis from settling in 60% of participants.
For those people, N. lactamica had locked out its deadly cousin. That drove work to make N. lactamica even more effective in displacing N. meningitidis.
The team did so by handing it one of N. meningitidis’ key weapons; a ‘sticky’ surface protein that grips the cells lining the nose. By inserting a copy of the gene for this protein into N. lactamica’s DNA, it could produce it too – levelling the playing field.
As well as inducing a stronger immune response, those modified bacteria stayed longer. Present for at least 28 days, with most participants (86%) still carrying it at 90 days, it caused no adverse symptoms.
The results of the study, which was funded by the Medical Research Council, are promising for this new way of preventing life-threatening infections, without drugs. It’s an approach that could be critical in the face of growing antimicrobial resistance.
Dr Jay Laver, Senior Research Fellow in Molecular Microbiology at the University of Southampton, commented: “Although this study has identified the potential of our recombinant N. lactamica technology for protecting people against meningococcal disease, the underlying platform technology has broader applications.
“It is theoretically possible to express any antigen in our bacteria, which means we can potentially adapt them to combat a multitude of infections that enter the body through the upper respiratory tract. In addition to the delivery of vaccine antigens, advances in synthetic biology mean we might also use genetically modified bacteria to manufacture and deliver therapeutics molecules in the near future.”
Prof Read, Director of the NIHR Southampton Biomedical Research Centre said: “This work has shown that it is possible to protect people from severe diseases by using nose drops containing genetically modified friendly bacteria. We think this is likely to be a very successful and popular way of protecting people against a range of diseases in the future.”
More from: University of Southampton
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Texas GOP Lt. Gov. 'Not A Mandate Guy' Despite Supporting Vaccination Mandate Previously
Dan Patrick, Texas' lieutenant governor, supported a vaccine mandate for college students as a state legislator in 2009.
- Lumbar puncture rates appropriately decline in children with simple febrile seizures
This multi-center study found that there was no significant difference in the rates of delayed bacterial meningitis diagnosis before and after the 2011 AAP guidelines to not perform a lumbar puncture ...
- Molecular Analysis of Echovirus 13 Isolates and Aseptic Meningitis, Spain
Echovirus 13 (EV13), considered rare, was reported worldwide in 2000, mostly related to aseptic meningitis outbreaks. In Spain, 135 EV13 isolates were identified. The genetic relationships between 64 ...
- Bill Nye’s humor finds an audience
Edgar Wilson “Bill Nye” (1850-1896) was editor of the Boomerang for two short years and might have continued longer had it not been for a nearly fatal bout with spinal ...
- Researchers find possible treatment strategy for Meningitis without antibiotics
Despite widespread implementation of vaccines bacterial meningitis is still associated with a high mortality rate and neurological consequences including heari ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Genetically modified friendly bacteria
- Using Insects to Revolutionize Agriculture, Tackle Climate Change, and Fight Future Pandemics
A preeminent thought leader in the use of insects as an alternative protein source, All Things Bugs discusses the genetic engineering of insects a ...
- Apples that fight decay
An apple a day could keep the dentist away - but only if it has been genetically modified, say British experts ... produce a protein that prevents the bacteria responsible for tooth decay from ...
- Gene therapy to fight breast disease
The treatment involves using a genetically modified virus to stop tumours migrating. So far, experiments have been conducted only on human cancer cells in the laboratory. But scientists at Cancer ...
- Scottish scientists begin novel experiment that could turn fish guts into green nylon for clothing
Fish offcuts could be used to create greener nylon and other synthetic materials if ground-breaking trials by Scottish scientists are successful.
- Living High-Altitude Balloon
However, conditions at such altitude are not particularly friendly and balloons have to ... the Stanford-Brown International Genetically Engineered Machine (iGEM) team designed microbes that ...